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INTRODUCTION
Healthcare-associated infections (HAI) are unintended consequences of care which are
recognized as a public health problem [1, 2]. They demand implementation of
preventative measures and many large scale institutional changes. However, around two-
thirds of organizations’ efforts to implement changes fail [3] due to barriers at various
levels of healthcare delivery such as the provider team, the health care organization, the
market, patients, and policy [3].
The (new) discipline of implementation science aims to understand the process of
implementation; not only to evaluate what works, but also to assess how it works and in
which context. This knowledge can be helpful in optimizing benefits, prolonging
sustainability and in promoting the dissemination of interventions into other contexts [4].
When analysing the implementation of preventative measures is helpful to use theoretical
frameworks such as the Consolidated Framework for Implementation Research (CFIR).
Elements within the CFIR include the intervention itself, the individuals involved, the
inner setting, the outer setting and the process. All of these elements are influenced by
public policies [3]. Therefore, public policy is key to the success of implementation of
measures to prevent HAIs.
There are complex power relationships underpinning policy formulations which are
dynamic and evolving. Overall, public policies tend to be more reactive than proactive in
responding to public demands. Agenda setting is the first stage in the public policy
process, being seen as a list of issues to which policy makers pay serious attention [5].
To move a topic higher up an agenda involves three elements: problems, proposals, and
politics. These elements combine to create a "policy window" [5]. In a policy window,
decision makers choose to pay attention to a specific topic. However, why one topic gets
attention while others do not, is a matter of study. This choice is usually influenced by
focusing events, which are "dramatic episodes that attract attention” [6]. This paper aims
to discuss leading focusing events, their limitations and other potential drivers for public
policies to prevent HAI.
Worldwide, the focusing events that create policy windows in HAI prevention have
included: nosocomial outbreaks, individual dramas of celebrities who have acquired
HAIs; major community epidemics and pandemics that affect infection control at
healthcare setting level; and antimicrobial resistance.
Nosocomial outbreaks are the most common focusing events as they have considerable
potential to capture the attention of both the media and the public, thus attracting the
attention of politicians. Nosocomial outbreaks have been focusing events since Ignaz
Semmelweiss, due to the deaths of women by puerperal infections in Vienna, and
Florence Nightingale, due to the deaths of British soldiers in the Crimean war.
Semmelweiss used a scientific demonstration to implement a new prevention strategy,
but despite a first successful experience, his work faded away relatively quickly, with no
further improvement. Conversely, Nightingale made better use of the policy window by
using a scientific demonstration in combination with her personal influence and
administrative empowerment to pursue future developments [7]. In her time, Nightingale
was considered a heroine by British soldiers, and by the media. She wrote many letters to
politicians about the improvement of care in hospitals not only in Britain but also in India,
where she influenced sanitary reform.
Outbreaks have served as focusing events, resulting in the development of national
programmes to prevent HAI, in (e.g.) Israel [8] and Chile. However, nosocomial
outbreaks may have limitations as focusing events to create a long lasting policy window.
This is because infection prevention professionals are (in general) unlikely to notify
outbreaks, [9] and outbreaks do not represent the real burden of HAI. Furthermore, the
sustainability of actions largely depends on the context, and many times efforts are only
addressed to solve the immediate problem with no follow-up.
An example of the personal drama of celebrity occurred in 1985 in Brazil, when President
Tancredo Neves died, supposedly due to HAI. At that time, Brazil already had a national
standard for hospital infection control committees (since 1983) but with no effective
adherence in many hospitals. Only after the president’s death were there more attempts
to audit preventative structures in hospitals. Nevertheless this potential focusing event
was forgotten and large-scale improvement did not happen as hoped. A celebrity drama
may produce an initial commotion, but in general does not last long enough to promote
sustained improvement. In fact, more than 10 years later, another severe nosocomial
outbreak which caused the deaths of 60 hemodialysis patients in Caruaru, Northwest
region, emerged as a focusing event [10]. This highlighted the urgent need for sanitary
audits to evaluate the quality of healthcare. As a result, after many years of hesitancy, the
national programme for HAI prevention was transferred in 1999 to the Brazilian National
Sanitary Agency which launched progressive action to achieve standardization and begin
monitoring and evaluation [11].
Pandemics and epidemics have also increased awareness of HAI prevention, mainly due
to concerns surrounding additional risks to healthcare personnel. These concerns were
exemplified during the first years of the HIV epidemic which brought much learning to
infection prevention in healthcare. Infection prevention was further boosted by media
coverage during other pandemics including SARS, Influenza, Ebola [12] and, more
recently, Middle East Respiratory Syndrome (MERS). High profile epidemics have
highlighted the pivotal role of infection prevention and control programmes in healthcare
services to international bodies such as the World Health Organization. These events also
raise awareness of preventative measures among healthcare workers as they have an
increased risk of contracting infectious diseases. Pandemics can reinforce standard
precautions, especially around the use of gloves, alcohol hand rubs, and single use
devices. The increased uptake of such measures increases the use of hygiene related
products, which tends to amplify the number of suppliers and large scale production thus
generating a reduction in their costs. Reduction of costs should minimize hesitation from
administrators in purchasing these items at the necessary quantity.
Finally, a potential focusing event is the emergence of antimicrobial resistance (AMR).
Currently considered as a global threat, combating AMR demands coordinated effort
across countries. This is a great policy window to drive efforts in infection prevention
with special attention to low and middle-income countries where AMR is elevated and
HAI may be 20 times higher than in high-income countries [1]. Although AMR is a topic
of interest shared by multiple groups, including patients, professionals, the health industry
and other industries (such as farming), perspectives may be controversial or contradictory
among stakeholders.
Other factors can be drivers (or influence them) for public policy to prevent HAI. Media
coverage is a powerful tool, both for good and evil. For instance, media coverage is one
of the reasons hospitals do not report outbreaks to health authorities [13]. Media can be
used politically by opposition groups to demonstrate poor management of public
hospitals and by lobby groups in defense of or against public or private services [14].
The health industry lobby can also affect drivers for public policy in HAI. This lobby
exerts influence on both politicians and society, often through media coverage.
Frequently, the industry lobby presents ‘silver bullet’ technologies to politicians and
hospital managers as the ultimate weapon to defeat HAIs.
International bodies may not act as direct drivers but may have a strong influence upon
them. The World Health Organization (WHO) has a long history of work against
pandemic and epidemics. Currently, WHO is putting much effort into combating HAI
and AMR [15-17]. The European Union is also addressing this issue by promoting HAI
prevention and measures against AMR by means of inter-country surveillance and
training programmes [18, 19]
Researchers and professionals often think that scientific evidence is a driver for
promoting public policies addressed to prevent HAI. Unfortunately, scientific evidence
does not reach a wide public and is rarely in the media. According to Boyce et al (2009)
“scientific articles, even those with the highest number of citations, have negligible
influence on newspaper coverage” [20]. It is proposed that, scientific evidence would
have greater effect during a policy window if it were used by researchers and
professionals to demonstrate improvement in the quality of health with minimal economic
impact. One can argue that the wider public might be a driver for public policies in HAI.
However, as with other issues, the public do not usually generate robust movements
unless there is a substantial financial cost. Often, the public do not differentiate between
an isolated clinical tragedy and a healthcare crisis. Society and professionals may have
different perceptions about this problem and policy alternatives to solve it. For healthcare
professionals, especially physicians, infection prevention is often seen as an intrusion
because measures interfere with their work. However, it is possible that the worldwide
movement for patient safety will lead to be a change in paradigms [15].
Seemingly, the understanding of health as a concept adopted by society as a whole may
be influential on the potential drivers. Health can be understood as a commodity or as a
citizen’s right depending on the values of the society. This affects access to healthcare;
in countries where access is arduous, the quality of care provided can be seen as a
secondary issue.
In conclusion, healthcare professionals and organizations should pay attention to factors
that potentially create policy windows which may favor the implementation process.
They should be prepared to act quickly and use all their knowledge and experience, to
create alternatives for sustainable public policy for effective HAI prevention and control
programmes.
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